Ma Y, Wan Y, Luo DH, Duan LG, Li L, Xia CQ, Chen XL. Direct in vivo injection of 131I-GMS and its distribution and excretion in rabbit. World J Gastroenterol 2010; 16(17): 2120-2128 [PMID: 20440852 DOI: 10.3748/wjg.v16.i17.2120]
Corresponding Author of This Article
Xiao-Li Chen, MD, Professor, The Research Unit of Hepato-Bilio-Pancreatology and Department of Hepatic Surgery, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China. zean_z@yahoo.com.cn
Article-Type of This Article
Original Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. May 7, 2010; 16(17): 2120-2128 Published online May 7, 2010. doi: 10.3748/wjg.v16.i17.2120
Table 1 Effect of washing on labeling rate (n = 6)
Number of washes
Labeling rate (%)
0
68.01 ± 2.09
1
47.74 ± 2.26
2
43.68 ± 2.19
3
42.72 ± 2.23
4
42.22 ± 2.27
5
41.91 ± 2.28
6
41.56 ± 2.27
7
41.00 ± 2.29
Table 2 Ratio of radioactivity between the liver and thyroid (n = 6) after the administration of 131I-labeled gelatin microspheres
Time
Liver/thyroid
4 h
15.910 ± 0.740
Day 4
27.197 ± 5.467
Day 8
81.467 ± 24.637
Day 16
91.670 ± 23.278
Day 24
93.601 ± 21.337
Day 32
112.608 ± 12.787
Day 48
162.875 ± 7.955
Table 3 Effects of the administration of 131I-labeled gelatin microspheres on hepatic function (n = 4)
ALT (IU/L)
AST (IU/L)
ALP (IU/L)
GGT (IU/L)
TP (g/L)
ALB (g/L)
GLB (g/L)
Before administration
67.75 ± 11.87
55.00 ± 11.87
99.75 ± 14.99
6.00 ± 1.83
54.33 ± 3.16
46.05 ± 2.32
8.28 ± 2.79
After administration
1 d
291.50 ± 12.79
146.00 ± 13.88
115.00 ± 25.92
9.25 ± 3.30
60.23 ± 1.96
45.65 ± 5.17
15.00 ± 5.34
4 d
46.75 ± 4.79
41.25 ± 10.69
91.00 ± 29.59
7.25 ± 1.26
58.43 ± 8.45
47.55 ± 3.53
12.23 ± 5.03
8 d
48.50 ± 14.39
48.00 ± 17.32
79.75 ± 14.77
7.50 ± 0.58
58.10 ± 4.40
44.63 ± 2.33
13.65 ± 4.33
16 d
37.25 ± 9.32
39.75 ± 11.81
76.00 ± 9.83
9.50 ± 3.11
62.13 ± 5.84
44.38 ± 7.41
19.85 ± 6.79
24 d
46.50 ± 16.01
45.25 ± 9.95
96.25 ± 17.08
8.00 ± 2.83
60.28 ± 4.45
47.60 ± 7.38
14.50 ± 3.54
32 d
52.25 ± 14.29
46.25 ± 8.66
96.75 ± 35.58
12.50 ± 3.87
63.55 ± 4.90
46.40 ± 4.06
18.63 ± 6.72
48 d
43.75 ± 10.01
40.25 ± 14.45
97.25 ± 7.93
9.25 ± 1.71
60.78 ± 4.08
46.83 ± 4.06
14.23 ± 4.22
64 d
45.50 ± 4.80
45.75 ± 3.24
91.75 ± 29.62
10.50 ± 3.42
61.92 ± 8.18
50.15 ± 5.30
15.05 ± 3.89
Table 4 Effects of the administration of 131I-labeled gelatin microspheres on thyroid function (n = 4)
FT3 (pmol/L)
FT4 (pmol/L)
TSH (mU/L)
Before administration
5.55 ± 0.57
19.61 ± 1.54
< 0.005
After administration
1 d
4.54 ± 1.53
19.31 ± 6.47
< 0.005
4 d
5.09 ± 1.68
21.31 ± 4.68
< 0.005
8 d
3.29 ± 0.83
14.23 ± 2.81
< 0.005
16 d
5.53 ± 1.01
19.95 ± 2.56
< 0.005
24 d
5.31 ± 0.57
20.39 ± 2.38
< 0.005
32 d
4.66 ± 2.17
19.18 ± 2.98
< 0.005
48 d
6.02 ± 2.77
20.94 ± 10.78
< 0.005
64 d
5.34 ± 1.34
21.23 ± 3.42
< 0.005
Citation: Ma Y, Wan Y, Luo DH, Duan LG, Li L, Xia CQ, Chen XL. Direct in vivo injection of 131I-GMS and its distribution and excretion in rabbit. World J Gastroenterol 2010; 16(17): 2120-2128